Concorde Asset Management, LLC Pfizer Inc Transaction History

Concorde Asset Management, LLC

$159 Million
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	BUY	$41.75 - $54.5 $2,045 - $2,670	49 Added 1.02%	4,830 $247,000
Q3 2022 Oct 31, 2022	BUY	$43.76 - $53.42 $209,216 - $255,401	4,781 New	4,781 $209,000
Q2 2022 Aug 05, 2022	SELL	$46.53 - $55.17 $247,865 - $293,890	-5,327 Closed	0 $0
Q1 2022 Apr 22, 2022	BUY	$45.75 - $56.69 $44,743 - $55,442	978 Added 22.49%	5,327 $276,000
Q4 2021 Feb 02, 2022	BUY	$41.32 - $61.25 $179,700 - $266,376	4,349 New	4,349 $257,000
Q2 2021 Jul 20, 2021	SELL	$35.91 - $40.68 $268,499 - $304,164	-7,477 Closed	0 $0
Q1 2021 Apr 27, 2021	SELL	$33.49 - $37.77 $20,227 - $22,813	-604 Reduced 7.47%	7,477 $270,000
Q4 2020 Jan 29, 2021	SELL	$33.47 - $42.56 $5,890 - $7,490	-176 Reduced 2.13%	8,081 $298,000
Q3 2020 Oct 23, 2020	SELL	$31.75 - $37.25 $81,851 - $96,030	-2,578 Reduced 23.79%	8,257 $302,000
Q2 2020 Jul 20, 2020	SELL	$30.12 - $36.54 $7,439 - $9,025	-247 Reduced 2.23%	10,835 $355,000
Q1 2020 Apr 22, 2020	BUY	$27.03 - $38.62 $64,412 - $92,031	2,383 Added 27.39%	11,082 $362,000
Q4 2019 Jan 30, 2020	BUY	$32.92 - $37.36 $11,785 - $13,374	358 Added 4.29%	8,699 $340,000
Q3 2019 Oct 28, 2019	SELL	$32.49 - $42.13 $50,781 - $65,849	-1,563 Reduced 15.78%	8,341 $300,000
Q2 2019 Aug 08, 2019	SELL	$36.98 - $41.52 $17,824 - $20,012	-482 Reduced 4.64%	9,904 $428,000
Q1 2019 May 01, 2019	BUY	$37.5 - $41.2 $42,900 - $47,132	1,144 Added 12.38%	10,386 $442,000
Q4 2018 Jan 25, 2019	BUY	$38.47 - $43.86 $108,754 - $123,992	2,827 Added 44.07%	9,242 $402,000
Q3 2018 Oct 30, 2018	BUY	$34.47 - $41.81 $482 - $585	14 Added 0.22%	6,415 $285,000
Q2 2018 Jul 17, 2018	BUY	$32.98 - $35.16 $211,104 - $225,059	6,401 New	6,401 $232,000
Q1 2018 Apr 24, 2018	SELL	$31.91 - $37.02 $212,137 - $246,108	-6,648 Closed	0 $0
Q4 2017 Jan 23, 2018	SELL	$33.26 - $35.29 $110,489 - $117,233	-3,322 Reduced 33.32%	6,648 $242,000
Q3 2017 Oct 31, 2017	BUY	$31.0 - $34.15 $309,070 - $340,475	9,970	9,970 $358,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

Vanguard Group Inc Valley Forge, PA

511M
Shares

$13.7 Billion
0.28% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.3 Billion
0.27% of portfolio
State Street Corp Boston, MA

287M
Shares

$7.67 Billion
0.36% of portfolio
Wellington Management Group LLP Boston, MA

166M
Shares

$4.44 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

117M
Shares

$3.13 Billion
0.63% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concorde Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Concorde Asset Management, LLC with notifications on news.

Account